Furthermore, AGEs and AGE-activated RAGE, linking glycation and inflammation, could potentially serve as metabolic and molecular signatures of malignant or metastatic cancers, and hence can be employed as prospective biomarkers, pertinent to cancer stage and individual tissue-specific expression. This evidence concerns the gene AGER and cancer.